semaglutide and masld in — the story is evolving. A stimulating discussion on how GLP-1 receptor agonists are reshaping the management of MASLD/MASH. Beyond consistent weight loss MASH resolution, emerging phase-3 data MASLD Outcomes Improved with Tirzepatide

I usually suggest taking it for two to eight weeks

The relationship between constipation and UTIs is particularly relevant for women, who already face higher baseline UTI risk due to anatomical factors

These changes collectively contribute to a breakdown in immune homeostasis, the Treg/Th17 balance shifts toward a pro-inflammatory state, Tfh cells promote B cell hyperactivation and autoantibody production, and mTOR pathway activation enhances glycolytic metabolism and inflammatory cytokine release in immune cells, ultimately leading to multitissue injury

They are full of vitamins and minerals

Serotonin syndrome following methylene blue administration for vasoplegic syndrome